MetasThera
Kraków, PL · 1 known investors
metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.
Investors · 1
Frequently asked questions
- What does MetasThera do?
- metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.
- Who are MetasThera's investors?
- MetasThera's investors include BSV Ventures.
- Where is MetasThera headquartered?
- MetasThera is headquartered in Kraków, PL.